Eye-tracking brain injury assessment device

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

TBI diagnostics Pty Ltd

classe:

Class IIa

Fabriqué par:

Oculogia Inc 33 Irving Place, New York, New York, 10003 United States Of America

Domaine thérapeutique:

65064 - Eye-tracking brain injury assessment device

indications thérapeutiques:

The EyeBOX is intended to measure and analyze eye movements as an aid in the diagnosis of concussion within one week of head injury in patients 5 through 67 years of age in conjunction with a standard neurological assessment of concussion. A negative EyeBOX classification may correspond to eye movement that is consistent with a lack of concussion. A positive EyeBOX classification corresponds to eye movement that may be present in both patients with or without concussion.

Statut de autorisation:

A

Date de l'autorisation:

2021-04-19